This study will investigate the safety and efficacy of different doses of an investigational drug as a therapy for HIV-infected patients failing current antiretroviral therapies.

Condition	Treatment or Intervention	Phase
HIV Infections Acquired Immunodeficiency Syndrome		Phase II Phase III

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

• Patient must be HIV positive with HIV RNA values that are within ranges required by the study.
• Patient must be currently on antiretroviral therapy (ART).

Exclusion Criteria:

• Patient less than 18 years of age.
• Additional exclusion criteria will be discussed and identified by the study doctor.

Call for Information      1-888-577-8839 

California
      Call for Information, Tarzana,  California,  91356,  United States; Recruiting
New York
      Call for Information, Albany,  New York,  12208,  United States; Recruiting
Pennsylvania
      Call for Information, Pittsburgh,  Pennsylvania,  15213,  United States; Recruiting

Study ID Numbers:  2005_007
Record last reviewed:  March 2005
Last Updated:  March 17, 2005
Record first received:  March 8, 2005
ClinicalTrials.gov Identifier:  NCT00105157
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08